Nasdaq:US$42.05 (+1.07) | HKEX:HK$70.60 (-7.00) | AIM:£5.95 (+0.03)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF